Patent application number | Description | Published |
20140050604 | PUMP - A pump comprising a side wall closed at each end by an end wall forming a cavity for, in use, containing a fluid, one or more actuators each operatively associated with one or more of the end walls to cause an oscillatory motion of the associated end wall(s) whereby, in use, these axial oscillations of the end wall(s) drive substantially radial oscillations of the fluid pressure in the cavity, two or more apertures in the cavity, a valve disposed in at least one of the apertures, wherein the actuator(s) is arranged to be non-axisymmetric in use such that, in use, a pressure oscillation with at least one nodal diameter is generated within the cavity. | 02-20-2014 |
20140338423 | ACOUSTIC SENSOR - An acoustic sensor includes a side wall, closed at each end by an end wall, to form a substantially cylindrical cavity, a transmitter and a receiver operatively associated with first and second respective end walls. Properties of the relative dimensions of the cavity are configured to create a desired oscillatory motion of the end walls, and oscillations of a fluid pressure in the cavity, to generate an electrical signal via the receiver to be output from the sensor. An array of acoustic sensors can be connected to allow calibration of one of the array of sensors. | 11-20-2014 |
20150023821 | DISC PUMP WITH ADVANCED ACTUATOR - A fluid pump comprising one or two cavities which, in use, contains a fluid to be pumped, the chamber or chambers having a substantially cylindrical shape bounded by first and second end walls and a side wall; an actuator which, in use, causes oscillatory motion of the first end wall(s) in a direction substantially perpendicular to the plane of the first end wall(s); and whereby, in use, these axial oscillations of the end walls drive radial oscillations of the fluid pressure in the main cavity; and wherein an isolator forms at least a portion of the first end wall between the actuator and the side wall and includes conductive tracks, wherein electrical connection is made to the actuator via the conductive tracks included within the isolator. | 01-22-2015 |
Patent application number | Description | Published |
20100044383 | CAN END - A can end having a countersink bead, an inclined chuck wall and a strong seam, resists distortion from its circular profile when subjected to thermal processing or when packaging carbonated beverages. This high hoop strength affects the manner in which the can end ultimately fails when placed under extreme abuse conditions, even if buckle pressure performance is within industry specified standards. The can end of the invention has control features introduced which control the failure mode whilst maintaining specified buckle pressure performance. In one embodiment, the can end has a two part wall and a control feature that comprises expansion of the countersink bead to act as a trigger for local peaking, together with a groove in the chuck wall which prevents the peaking force from being concentrated at a single point which could result in leaking by the production of a pin hole. | 02-25-2010 |
20110056945 | FULL APERTURE BEVERAGE END - A full aperture beverage end has a center panel, a countersink surrounding the centre panel, a main score arranged in proximity to the countersink to define a removable aperture panel and a vent score. The beverage end is adapted for use with products that are pressurized to over 30 psi (200 kPa) when opened, and during opening the vent score is adapted to sever first, controlling the pressure differential between the external surface and internal surface of the centre panel, thereby allowing the main score to tear in a controlled and reliable manner. | 03-10-2011 |
20120175376 | Can End - A can end having a countersink bead, an inclined chuck wall and a strong seam, resists distortion from its circular profile when subjected to thermal processing or when packaging carbonated beverages. This high hoop strength affects the manner in which the can end ultimately fails when placed under extreme abuse conditions, even if buckle pressure performance is within industry specified standards. The can end of the invention has control features introduced which control the failure mode whilst maintaining specified buckle pressure performance. In one embodiment, the can end has a two part wall and a control feature that comprises expansion of the countersink bead to act as a trigger for local peaking, together with a groove in the chuck wall which prevents the peaking force from being concentrated at a single point which could result in leaking by the production of a pin hole. | 07-12-2012 |
20120269934 | FULL APERTURE BEVERAGE CAN END - The present invention concerns a full aperture beverage end ( | 10-25-2012 |
20130306658 | Can End - A can end having a countersink bead, an inclined chuck wall and a strong seam, resists distortion from its circular profile when subjected to thermal processing or when packaging carbonated beverages. This high hoop strength affects the manner in which the can end ultimately fails when placed under extreme abuse conditions, even if buckle pressure performance is within industry specified standards. The can end of the invention has control features introduced which control the failure mode whilst maintaining specified buckle pressure performance. In one embodiment, the can end has a two part wall and a control feature that comprises expansion of the countersink bead to act as a trigger for local peaking, together with a groove in the chuck wall which prevents the peaking force from being concentrated at a single point which could result in leaking by the production of a pin hole. | 11-21-2013 |
Patent application number | Description | Published |
20130276289 | TOLERANCE RING AND ASSEMBLY WITH DEFORMABLE PROJECTIONS - A method of assembling a tolerance ring between opposing surfaces of an inner and outer component arranged to mate with one another to provide an interference fit therebetween includes mounting the tolerance ring on one of the inner and outer components whereby the projections are received in a recessed portion on that component, partially mating the inner and outer components, and completing mating by causing relative movement between the tolerance ring and the recessed portion to move the projections from the recessed portion and to be compressed between the mated inner and outer components. The tolerance ring includes an annular band of resilient material for engaging an opposing surface of one of the inner and outer components. The annular band has a plurality of deformable projections extending radially therefrom to engage the opposing surface of the other one of the inner and outer components. | 10-24-2013 |
20130315654 | TOLERANCE RING WITH PERFORATED WAVES - A tolerance ring is disclosed and can include a generally cylindrical body that can include a side wall. The sidewall can define a top and a bottom. Further, the sidewall can include a plurality of wave structures that can extend from the sidewall, a plurality of unformed sections, and a gap that can extend along the entire length of the body. Each unformed section can be located between a pair of adjacent wave structures. Further, the gap can establish a split in the body. The tolerance ring can also include at least one hole intersecting at least one of the wave structures to establish a perforated wave structure. | 11-28-2013 |
20130315655 | TOLERANCE RING WITH SLOTTED SIDEWALL - A tolerance ring is disclosed and can include a generally cylindrical body having a sidewall. The sidewall can include a plurality of wave structures extending from the sidewall at regular intervals around the body, a first unformed section between a first pair of adjacent wave structures, and a second unformed section between a second pair of adjacent wave structures. The gap can extend along an entire length, L, of the body to establish a split in the body. The second unformed section can include a slot therein. The slot can have a length, L | 11-28-2013 |
20130315664 | TOLERANCE RING WITH GROUPED WAVES - A tolerance ring is disclosed and can include a generally cylindrical body having a sidewall. The sidewall can include a first unformed section and a gap in the first unformed section. The gap can extend along an entire length of the body to establish a split in the body. The sidewall can also include a second unformed section opposite the first unformed section, a first wave bank flanking the first unformed section with the gap, and a second wave bank flanking the first unformed section with the gap. The wave banks can be equally spaced around a circumference of the body of the tolerance ring and the body of the tolerance ring can be symmetrical about a center axis that extends from a center of the tolerance ring and bisects the gap in the first unformed section. | 11-28-2013 |
Patent application number | Description | Published |
20110172189 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. Formula (I). | 07-14-2011 |
20110190302 | Aryl-Phenyl-Sulfonamide-Phenylene Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 08-04-2011 |
Patent application number | Description | Published |
20130245018 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 09-19-2013 |
Patent application number | Description | Published |
20150141472 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 05-21-2015 |
20150266815 | Aryl-Phenyl-Sulfonamido-Cycloalkyl Compounds and Their Use - The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”). The present invention also pertains to pharmaceutical compositions comprising such compounds, and the use of such compounds and compositions, both in vitro and in vivo, in treatment, for example, of inflammation and/or joint destruction and/or bone loss; of disorders mediated by excessive and/or inappropriate and/or prolonged activation of the immune system; of inflammatory and autoimmune disorders, for example, rheumatoid arthritis, psoriasis, psoriatic arthritis, chronic obstructive pulmonary disease (COPD), atherosclerosis, inflammatory bowel disease, ankylosing spondylitis, and the like; of disorders associated with bone loss, such as bone loss associated with excessive osteoclast activity in rheumatoid arthritis, osteoporosis, cancer-associated bone disease, Paget's disease and the like, etc.; and of cancer, such as a haematological malignancy, a solid tumour, etc. | 09-24-2015 |